Intrinsic Value of S&P & Nasdaq Contact Us

Eisai Co., Ltd. ESALF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • JP • USD

SharesGrow Score
79/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Eisai Co., Ltd. (ESALF) trades at a trailing P/E of 0.2, forward P/E of 0.2. Trailing earnings yield is 555.56%, forward earnings yield 526.32%. PEG 0.02 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — P/E is below market average (0.2); PEG ≤ 1.0 — Peter Lynch undervalued (0.02); earnings yield beats bond yields (555.56%).
  • PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 555.56% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 76/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
79/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
82/100
→ Income
~
GROWTH
45/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — ESALF

Valuation Multiples
P/E (TTM)0.2
Forward P/E0.2
PEG Ratio0.02
Forward PEG0.01
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$163.76
Forward EPS (Est.)$160.63
Book Value / Share$0.00
Revenue / Share$2,784.12
FCF / Share$0.00
Yields & Fair Value
Earnings Yield555.56%
Forward Earnings Yield526.32%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $191.76 $547.92B $54.93B 10%
2017 $137.41 $539.1B $39.36B 7.3%
2018 $180.97 $600.05B $51.85B 8.6%
2019 $221.12 $642.83B $63.39B 9.9%
2020 $424.80 $695.62B $121.77B 17.5%
2021 $146.90 $645.94B $41.94B 6.5%
2022 $167.25 $756.23B $47.95B 6.3%
2023 $193.30 $744.4B $55.43B 7.4%
2024 $147.86 $741.75B $42.41B 5.7%
2024 $163.76 $789.4B $46.43B 5.9%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message